<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus - rgpv timetable Microsoft Word - M Pharm PCI Syllabus all branches</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 .p, p { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; margin:0pt; }
 .s3 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; vertical-align: 2pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 2; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: c2 1; }
 #l2> li>*:first-child:before {counter-increment: c2; content: counter(c2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: c2 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 2; }
 #l3> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l4 {padding-left: 0pt;counter-reset: d2 1; }
 #l4> li>*:first-child:before {counter-increment: d2; content: counter(d2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 li {display: block; }
 #l5 {padding-left: 0pt; }
 #l5> li>*:first-child:before {content: "□ "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 li {display: block; }
 #l6 {padding-left: 0pt;counter-reset: f1 2; }
 #l6> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 #l7 {padding-left: 0pt;counter-reset: f2 1; }
 #l7> li>*:first-child:before {counter-increment: f2; content: counter(f2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: f2 0;  }
 #l8 {padding-left: 0pt;counter-reset: g1 2; }
 #l8> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: g1 0;  }
 #l9 {padding-left: 0pt;counter-reset: g2 1; }
 #l9> li>*:first-child:before {counter-increment: g2; content: counter(g2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: g2 0;  }
 #l10 {padding-left: 0pt;counter-reset: h1 1; }
 #l10> li>*:first-child:before {counter-increment: h1; content: counter(h1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l10> li:first-child>*:first-child:before {counter-increment: h1 0;  }
</style><link rel="sitemap" type="application/xml" title="Sitemap" href="/sitemap.xml"></head><body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download</button></a></div><script>const a=(window.location.pathname).split(/);const filename=a[a.length-1].replace(".html",".pdf").replace(".htm",".pdf");document.getElementById("pdf-download-link").href=filename;</script><p class="s1" style="padding-top: 3pt;padding-left: 140pt;text-indent: -116pt;line-height: 112%;text-align: left;">ADVANCED BIOPHARMACEUTICS &amp; PHARMACOKINETICS (MIP 201T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course is designed to impart knowledge and skills necessary for dose calculations, dose adjustments and to apply Biopharmaceutics theories in practical problem solving.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: justify;">On completion of this course it is expected that students will be able to understand,</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">  <span class="p">The basic concepts in Biopharmaceutics and pharmacokinetics.</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 86%;text-align: justify;"> <span class="p">The use of raw data and derive the pharmacokinetic models and parameters the best describe the process of drug absorption, distribution, metabolism and elimination.</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: justify;"> <span class="p">To critically evaluate Biopharmaceutics studies involving drug product equivalency.</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: justify;"> <span class="p">To design and evaluate dosage regimens of the drugs using pharmacokinetic and biopharmaceutic parameters.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1.  <span class="s2">Drug  Absorption  From  The   Gastrointestinal   Tract</span>: Gastrointestinal tract, Mechanism of drug absorption, Factors affecting, pH–partition theory, Formulation and physicochemical factors: Dissolution rate, Dissolution process, Noyes–Whitney equation and drug dissolution, Factors affecting the dissolution rate. Gastrointestinal absorption: role of the dosage form: Solution (elixir, syrup and solution) as a dosage form ,Suspension as a dosage form, Capsule as a dosage form, Tablet as a dosage form</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 10pt;text-align: justify;">,Dissolution methods ,Formulation and processing factors,</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Correlation of in vivo data with in vitro dissolution data. Transport model: Permeability-Solubility-Charge State and the pH Partition Hypothesis, Properties of the Gastrointestinal Tract (GIT), pH Microclimate  Intracellular  pH  Environment,  Tight-Junction Complex. Solubility: Experimental methods. Permeability: In-vitro, in-situ and In-vivo methods.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l1"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Biopharmaceutic  Considerations  in  Drug  Product  Design and  In  Vitro  Drug  Product  Performance<span class="p">:  Introduction, Biopharmaceutic Factors Affecting Drug Bioavailability, Rate- Limiting Steps in Drug Absorption, Physicochemical Nature of the</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Drug Formulation Factors Affecting Drug Product Performance, <span class="s2">In Vitro</span>: Dissolution and Drug Release Testing, Compendial Methods of Dissolution, Alternative Methods of Dissolution Testing, Meeting Dissolution Requirements, Problems of Variable Control in Dissolution Testing Performance of Drug Products: <span class="s2">In Vitro</span>–<span class="s2">In Vivo </span>Correlation, Dissolution Profile Comparisons, Drug Product Stability, Considerations in the Design of a Drug Product.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Pharmacokinetics<span class="p">:  Basic  considerations,  Pharmacokinetic models, Compartment modeling: One compartment model- IV bolus, IV infusion, Extra-vascular; Multi Compartment model: Two compartment - model in brief, Non-Linear Pharmacokinetics: Cause of non-linearity, Michaelis – Menten equation, Estimation Kmax and Vmax. Drug interactions: Introduction, The effect of protein-binding interactions, The effect of tissue-binding interactions, Cytochrome P450-based drug interactions, Drug interactions linked to transporters.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Drug  Product  Performance,  In  Vivo:  Bioavailability  and Bioequivalence<span class="p">: Drug Product Performance, Purpose of Bioavailability Studies, Relative and Absolute Availability, , Methods for Assessing Bioavailability, Bioequivalence Studies, Design and Evaluation of Bioequivalence Studies, Study Designs, Crossover Study Designs, Evaluation of the Data, Bioequivalence Example, Study Submission and Drug Review Process, The Biopharmaceutics Classification System, Generic Biologics (Biosimilar Drug Products),Clinical Significance of Bioequivalence Studies, Special Concerns in Bioavailability and Bioequivalence Studies, Generic Substitution.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Application of  Pharmacokinetics:  <span class="p">Modified-Release  Drug Products, Targeted Drug Delivery Systems and Biotechnological Products. Relationship between Pharmacokinetics including Pharmacodynamics: Generation of a pharmacokinetic– pharmacodynamic (PKPD) equation, Pharmacokinetic and pharmacodynamic,    interactions. Pharmacokinetics and pharmacodynamics of biotechnology drugs: Introduction, Proteins and peptides, Monoclonal antibodies, Oligonucleotides, Vaccines (immunotherapy),Gene therapies.</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l2"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Biopharmaceutics and Clinical Pharmacokinetics by Milo Gibaldi, 4<span class="s3">th </span>edition,Philadelphia, Lea and Febiger, 1991</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Biopharmaceutics and Pharmacokinetics, A. Treatise, D .M. Brahmankar and Sunil B.J aiswal., Vallab Prakashan, Pitampura, Delhi</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 83%;text-align: justify;">Applied Biopharmaceutics and Pharmacokinetics by Shargel. Land YuABC, 2<span class="s3">nd </span>edition, Connecticut Appleton Century Crofts, 1985</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Textbook of Biopharmaceutics and Pharmacokinetics, Dr. Shobha Rani R. Hiremath,Prism Book</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Pharmacokinetics by Milo Gibaldi and D. Perrier, 2nd edition, Marcel Dekker Inc.,New York, 1982</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: justify;">Current Concepts in Pharmaceutical Sciences: Biopharmaceutics, Swarbrick. J, Lea and Febiger, Philadelphia, 1970</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Clinical Pharmacokinetics, Concepts and Applications 3rd edition by Malcolm Rowland and Thom~ N. Tozer, Lea and Febiger, Philadelphia, 1995</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Dissolution, Bioavailability and Bioequivalence, Abdou. H.M, Mack Publishing Company, Pennsylvania 1989</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Biopharmaceutics and Clinical Pharmacokinetics, An Introduction, 4th edition, revised and expande by Robert. E. Notari, Marcel Dekker Inc, New York and Basel,1987.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: justify;">Biopharmaceutics and Relevant Pharmacokinetics by John. G Wagner and M.Pemarowski, 1st edition, Drug Intelligence Publications, Hamilton, Illinois, 1971.</p></li><li data-list-text="11."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Encyclopedia of Pharmaceutical Technology, Vol 13, James Swarbrick, James. G.Boylan, Marcel Dekker Inc, New York, 1996.</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Basic Pharmacokinetics,1 st edition, Sunil S Jambhekar and Philip J Breen,pharmaceutical press, RPS Publishing,2009.</p></li><li data-list-text="13."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: justify;">Absorption and Drug Development- Solubility, Permeability, and Charge State, Alex Avdeef, John Wiley &amp; Sons, Inc,2003.</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 65pt;text-indent: 0pt;line-height: 113%;text-align: center;">SCALE UP AND TECHNOLOGY TRANSFER (MIP 202T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 87%;text-align: justify;">This course is designed to impart knowledge and skills necessary to train the students to be on scale up, technology transfer process and industrial safety issues.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives:</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: left;">On completion of this course it is expected that students will be able to understand,</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Manage the scale up process in pharmaceutical industry.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Assist in technology transfer.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">To establish safety guidelines, which prevent industrial hazards.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 14pt;text-indent: 0pt;text-align: center;">THEORY                                60 Hrs</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1. <span class="s2">Pilot plant design: </span>Basic requirements for design, facility, equipment selection, for tablets, capsules, liquid orals, parentral and semisolid preparations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Scale up: <span class="p">Importance, Technology transfer from R &amp; D to pilot plant to plant scale, process scale up for tablets, capsules, liquid orals, semisolids, parentral, NDDS products – stress on formula, equipments, product uniformity, stability, raw materials, physical layout, input, in-process and finished product specifications, problems encountered during transfer of technology</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l3"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Validation: <span class="p">General concepts, types, procedures &amp; protocols, documentation, VMF. Analytical method validation, cleaning validation and vender qualification.</span></p></li><li data-list-text="3"><p class="s2" style="padding-top: 1pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Equipment Qualification: <span class="p">Importance, IQ,  OQ,  PQ  for equipments – autoclave, DHS, membrane filter, rapid mixer granulator, cone blender, FBD, tablet compression machine, liquid filling and sealing machine. Aseptic room validation.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Process  validation:  <span class="p">Importance, validation of  mixing, granulation, drying, compression, tablet coating, liquid filling and sealing, sterilization, water process systems, environmental control.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="5"><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Industrial safety: <span class="p">Hazards – fire, mechanical, electrical, chemical and pharmaceutical, Monitoring &amp; prevention systems, industrial effluent testing &amp; treatment. Control of environmental pollution.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l4"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Pharmaceutical process validation, JR Berry, Nash, Vol 57, Marcel Dekker, NY.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Pharmaceutical Production facilities, design and applications, by GC Cole, Taylor and Francis.</p></li><li data-list-text="3."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Pharmaceutical project management, T.Kennedy, Vol 86, Marcel Dekker, NY.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 9pt;text-align: left;">The theory &amp; Practice of Industrial Pharmacy, L.Lachman, H.A.Lieberman,</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Varghese Publ. Bombay.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Tablet machine instruments in pharmaceuticals, PR Watt, John Wiloy.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Pharmaceutical dosage forms, Tablets, Vol 1, 2, 3 by Lachman, Lieberman, Marcel Dekker, NY.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Pharmaceutical dosage forms, Parentral medications, Vol 1, 2 by K.E. Avis, Marcel Dekker, NY.</p></li><li data-list-text="8."><p class="s2" style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">	<span class="p">Dispersed system Vol 1, 2, 3 by Lachman, Lieberman, Marcel Dekker, NY.</span></p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: left;">Subrahmanyam, CVS, Pharmaceutical production and Management, 2007, Vallabh Prakashan,Dehli.</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 140pt;text-indent: -93pt;line-height: 113%;text-align: left;">PHARMACEUTICAL PRODUCTION TECHNOLOGY (MIP 203T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 87%;text-align: left;">This course is designed to impart knowledge and skills necessary to train the students to be on par with the routine of Industrial activities in Production</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">On completion of this course it is expected that students will be able to understand,</p><ul id="l5"><li data-list-text="□"><p style="padding-left: 77pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Handle the scheduled activities in a Pharmaceutical firm.</p></li><li data-list-text="□"><p style="padding-left: 77pt;text-indent: -18pt;line-height: 85%;text-align: left;">Manage the production of large batches of pharmaceutical formulations.</p></li></ul><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                               60 Hrs</p><p class="s2" style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Improved Tablet Production: <span class="p">Tablet production process, unit</span></p><p style="padding-top: 1pt;padding-left: 27pt;text-indent: -22pt;line-height: 84%;text-align: justify;">1. operation improvements, granulation and pelletization equipments, continuous and batch mixing, rapid mixing granulators, rota granulators, spheronizers and marumerisers, and other specialized granulation and drying equipments. Problems encountered.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: justify;">Coating Technology: <span class="p">Process, equipments, particle coating, fluidized bed coating, application techniques.   Problems encountered.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l6"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Parenteral Production: <span class="p">Area planning &amp; environmental control, wall and floor treatment, fixtures and machineries, change rooms, personnel flow, utilities &amp; utilities equipment location, engineering and maintenance.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 88%;text-align: justify;">Lyophilization  &amp;  Spray  drying  Technology:  <span class="p">Principles, process, freeze-drying and spray drying equipments.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Capsule Production: <span class="p">Production process, improved capsule manufacturing and filling machines for hard and soft gelatin capsules. Layout and problems encountered.</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: justify;">Disperse  Systems  Production:    <span class="p">Production processes, applications of mixers, mills, disperse equipments including fine solids dispersion, problems encountered.</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: left;">Packaging  Technology:    <span class="p">Types of packaging materials, machinery, labeling, package printing for different dosage forms.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Air Handling Systems: <span class="p">Study of AHUs, humidity &amp; temperature control, air filtration systems, dust collectors. </span>Water Treatment Process: <span class="p">Techniques and maintenance – RO, DM, ultra – filtration, WFI.</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l7"><li data-list-text="1."><p style="padding-top: 7pt;padding-left: 26pt;text-indent: -14pt;line-height: 71%;text-align: left;">The Theory &amp; Practice of Industrial Pharmacy, L. Lachman, Varghese Publ, Bombay.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Modern Pharmaceutics by Banker, Vol 72, Marcel Dekker, NY.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Pharmaceutical Dosage Forms, Vol 1, 2, 3 by Lachman, Lieberman, Marcel Dekker, NY.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Pharmaceutical Dosage Forms, Parentral medications, Vol 1, 2 by K.E. Avis, Marcel Dekker, NY.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Pharmaceutical Production Facilities, design and applications, by G.C. Cole, Taylor and Francis.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 10pt;text-align: left;">Dispersed System Vol 1, 2, 3 by Lachman, Lieberman, Marcel Dekker, NY.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Product design and testing of polymeric materials by N.P. Chezerisionoff.</p></li><li data-list-text="8."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Pharmaceutical Project Management, T.Kennedy, Vol 86, Marcel Dekker, NY.</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Packaging Pharmaceutical and Health Care, H.Lockhard.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Quality Control of Packaging Materials in Pharmaceutical Industy,</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 12pt;text-align: left;">.Kharburn, Marcel Dekker, NY.</p></li><li data-list-text="11."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Freeze drying / Lyophilization of Pharmaceuticals &amp; Biological Products, L. Ray, Vol 96, Marcel Dekker, NY.</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 83%;text-align: left;">Tablet Machine Instrumentation In Pharmaceuticals, PR Watt, Ellis Horwoods, UK.</p><p class="s1" style="padding-top: 3pt;padding-left: 140pt;text-indent: -65pt;line-height: 113%;text-align: left;">ENTREPRENEURSHIP MANAGEMENT (MIP 204T)</p><p class="s2" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">This course is designed to impart knowledge and skills necessary to train the students on entrepreneurship management.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives:</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: left;">On completion of this course it is expected that students will be able to understand,</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">The Role of enterprise in national and global economy</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Dynamics of motivation and concepts of entrepreneurship</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Demands and challenges of Growth Strategies And Networking</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1. <span class="s2">Conceptual Frame Work: </span>Concept need and process in entrepreneurship development. Role of enterprise in national and global economy. Types of enterprise – Merits and Demerits. Government policies and schemes for enterprise development. Institutional support in enterprise development and management.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l8"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Entrepreneur: <span class="p">Entrepreneurial  motivation  –  dynamics  of motivation. Entrepreneurial competency –Concepts. Developing Entrepreneurial competencies - requirements and understanding the process of entrepreneurship development, self-awareness, interpersonal skills, creativity, assertiveness, achievement, factors affecting entrepreneur role.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Launching And  Organising  An  Enterprise:  <span class="p">Environment scanning – Information, sources, schemes of assistance, problems. Enterprise selection, market assessment, enterprise feasibility study, SWOT Analysis. Resource mobilisation - finance, technology, raw material, site and manpower. Costing and marketing management and quality control. Feedback, monitoring and evaluation.</span></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">Growth Strategies And Networking: <span class="p">Performance appraisal and assessment. Profitability and control measures, demands and challenges. Need for diversification. Future Growth – Techniques of expansion and diversification, vision strategies. Concept and dynamics. Methods, Joint venture, co-ordination and feasibility study.</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="5"><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 79%;text-align: left;">Preparing Project Proposal To Start On New Enterprise <span class="p">Project work – Feasibility report; Planning, resource mobilisation and implementation.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l9"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Akhauri, M.M.P.(1990): Entrepreneurship for Women in India, NIESBUD, New Delhi.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 10pt;text-align: left;">Hisrich, R.D &amp; Brush, C.G.(1996) The Women Entrepreneurs, D.C. Health</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 13pt;text-align: left;">&amp; Co., Toranto.</p></li><li data-list-text="3."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Hisrich, R.D. and Peters, M.P. (1995): Entrepreneurship – Starting, Developing and Managing a New Enterprise, Richard D., Inwin, INC, USA.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Meredith, G.G. etal (1982): Practice of Entrepreneurship, ILO, Geneva.</p></li><li data-list-text="5."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 83%;text-align: left;">Patel, V.C. (1987): Women Entrepreneurship – Developing New Entrepreneurs, Ahmedabad EDII.</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 143pt;text-indent: -72pt;line-height: 113%;text-align: left;">INDUSTRIAL PHARMACY PRACTICAL - II (MIP 205P)</p><ol id="l10"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 19pt;text-indent: -13pt;line-height: 85%;text-align: left;">Improvement of dissolution characteristics of slightly soluble drug by Solid dispersion technique.</p></li><li data-list-text="2."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 10pt;text-align: left;">Comparison of dissolution of two different marketed products /brands</p></li><li data-list-text="3."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 86%;text-align: left;">Protein binding studies of a highly protein bound drug &amp; poorly protein bound drug</p></li><li data-list-text="4."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 10pt;text-align: left;">Bioavailability studies of Paracetamol (Animal).</p></li><li data-list-text="5."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Pharmacokinetic and IVIVC data analysis by WinnolineR software</p></li><li data-list-text="6."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 12pt;text-align: left;">In vitro cell studies for permeability and metabolism</p></li><li data-list-text="7."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Formulation and evaluation of tablets</p></li><li data-list-text="8."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Formulation and evaluation of capsules</p></li><li data-list-text="9."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">Formulation and evaluation of injections 10.Formulation and evaluation of emulsion 11.Formulation and evaluation of suspension. 12.Formulation and evaluation of enteric coating tablets.</p></li></ol></li><li data-list-text="13."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 91%;text-align: left;">Preparation and evaluation of a freeze dried formulation. 14.Preparation and evaluation of a spray dried formulation.</p></li></ol></li></ol></body></html>
